Início › Câncer de Cólon › Nova York › New York City
Ensaios clínicos de Câncer de Cólon em New York City, NY
22 estudos para Câncer de Cólon estão buscando participantes em locais em New York City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RecrutandoFase 3
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecrutandoFase 3
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecrutandoFase 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RecrutandoFase 3
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Recrutando
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RecrutandoFase 2/3
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- Manhattan Eye Ear and Throat Hospital, New York
- e mais 2
Shield Post-Approval Study Protocol
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- NYU Langone, New York
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RecrutandoFase 1
- Xencor Investigative Site, New York
- Xencor Investigative Site, New York
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- NYU Langone Medical Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RecrutandoFase 1
- Research Site, New York
- Research Site, New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
RecrutandoFase 1
- Columbia University Irving Medical Center, New York
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
RecrutandoEstudo observacional
- NYU Langone Health, New York
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RecrutandoEstudo observacional
- Memorial Sloan Kettering Cancer Center, New York
Phase II Trial of Lung Chemoemobolization
RecrutandoFase 2
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Memorial Sloan Kettering Cancer Center, New York
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
RecrutandoFase 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- e mais 1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- NYU Langone Health, New York
Ensaios de Câncer de Cólon em outras cidades
- Boston, MA22 estudos
- Houston, TX20 estudos
- Los Angeles, CA16 estudos
- Nashville, TN16 estudos
- St. Louis, MO15 estudos
- Arlington, VA15 estudos
- Chicago, IL14 estudos
- San Antonio, TX14 estudos
- Baldwin Park, CA14 estudos
- Baltimore, MD13 estudos
- Tampa, FL13 estudos
- Washington, DC12 estudos
Outros estudos em New York City
- Câncer de Mama136 estudos
- Câncer de Pulmão de Não Pequenas Células121 estudos
- Câncer (todos os tipos)109 estudos
- Câncer de Próstata103 estudos
- Câncer Metastático93 estudos
- Câncer Colorretal78 estudos
- Câncer de Ovário69 estudos
- Câncer de Pulmão60 estudos
- Mieloma Múltiplo60 estudos
- Câncer de Pâncreas60 estudos
- Câncer Endometrial52 estudos
- Leucemia Mieloide Aguda51 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.